Who
Isaac Barchas
Director
Company insider
Files Form 4 as: Director, Immunome; Other, TMC the metals company.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $28.2M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 9 Sep 2021
- Last trade
- 12 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 12 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $301K11,048 at $27.25 | filing |
| 12 Aug 2026filed 12 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $301K11,048 at $27.25 | filing |
| 11 Aug 2026filed 12 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $1.6M62,291 at $26.23 | filing |
| 11 Aug 2026filed 12 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $1.6M62,291 at $26.23 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $264K10,125 at $26.07 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $264K10,125 at $26.07 | filing |
| 7 Aug 2026filed 10 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $397K15,248 at $26.06 | filing |
| 7 Aug 2026filed 10 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $397K15,248 at $26.06 | filing |
| 6 Aug 2026filed 10 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $543K20,840 at $26.06 | filing |
| 6 Aug 2026filed 10 Aug 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $543K20,840 at $26.06 | filing |
| 7 Jul 2026filed 7 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $409K16,906 at $24.20 | filing |
| 7 Jul 2026filed 7 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $409K16,906 at $24.20 | filing |
| 6 Jul 2026filed 7 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $2.0M83,094 at $24.11 | filing |
| 6 Jul 2026filed 7 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $2.0M83,094 at $24.11 | filing |
| 2 Jul 2026filed 2 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $1.7M75,665 at $22.35 | filing |
| 2 Jul 2026filed 2 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $568K24,335 at $23.33 | filing |
| 2 Jul 2026filed 2 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $1.7M75,665 at $22.35 | filing |
| 2 Jul 2026filed 2 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $568K24,335 at $23.33 | filing |
| 30 Jun 2026filed 2 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $2.1M101,050 at $21.12 | filing |
| 30 Jun 2026filed 2 Jul 2026 | IMNM ImmunomeBiotechnology | SEC FORM 4 Sold | $2.1M101,050 at $21.12 | filing |
News
Arbutus Biopharma (NASDAQ:ABUS) vs. Immunome (NASDAQ:IMNM) Financial ComparisonIMNM · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Isaac Barchas; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.